CTRI/2024/07/070040尚未招募Unknown
Evaluation Of Serum and Salivary Mitofusin-1 and Mitofusin-2 and its Association with Periodontal Diseases and Atherosclerotic Cardiovascular Diseases - NI
Kaviyapriya.A0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Inclusion criteria for healthy individuals:
- •Based on the classification system introduced by Kornman and Tonetti et al, 2018.
- •1. Pristine periodontal health:
- •· No bleeding on probing.
- •· Normal gingival sulcus depth.
- •· Normal bone heights.
- •· Controlled modifying factors.
- •· Controlled predisposing factors.
- •2.Clinical periodontal health (intact periodontium):
- •· No or minimal bleeding on probing.
- •· Normal gingival sulcus depth.
- •· Normal bone heights.
- •· Controlled modifying factors.
- •· Controlled predisposing factors.
- •IInclusion criteria for Stage III/IV Periodontitis:
- •Based on the classification system introduced by Kornman and Tonetti et al, 2018.
- •1.Stage III:
- •Interdental clinical attachment loss at site of greatest loss = 5mm.
- •Radiographic bone loss extending to middle or apical third of root
- •Tooth loss due to periodontitis = 4 teeth.
- •Probing depth = 6mm.
- •Extent: Greater than 30% of teeth involved (Generalized)
- •2.Stage IV:
- •Interdental clinical attachment loss at site of greatest loss = 5mm.
- •Radiographic bone loss extending to middle or apical third of root
- •Tooth loss due to periodontitis = 5 teeth.
- •Extent: Greater than 30% of teeth involved (Generalized)
- •Atherosclerosis in this study is defined as an event of Acute Myocardial Infarction, Acute coronary syndrome, patients with defined coronary artery disease (Coronary angiography) and patients post bypass and post stenting. Patients with aortic aneurysms (pathogenesis –atherosclerosis)
- •Inclusion criteria for cardiovascular patients:
- •1.History of angina and not consuming lipid lowering drugs(statins)
- •2.Borderline high to high lipid profile inclusive of total cholesterol, Triglycerides and LDL (As per NCEP-ATP III classification)
- •a. Total cholesterol level above 200 mg/dL
- •b. Triglycerides above 150 mg/dL
- •c.HDL above 60 mg/dL
- •d.LDL above 130mg/dL
排除标准
- •1.Patients with immunodeficiency disorders.
- •2.Patients with other systemic inflammatory conditions like sepsis, pneumonia, pleural effusion, intra-abdominal infections, inflammatory bowel disorders, inflammatory rheumatoid disorders, chronic kidney disease, Diabetes, cancers, COPD, asthma, HIV and hepatitis will be excluded from the study.
- •3.History of periodontal treatment within the last 6 months.
- •4.History of antibiotic therapy in the past 3 months.
- •5.Subjects who are not willing to participate in the study.
研究者
相似试验
尚未招募
不适用
Periodontal Disease and Salivary Mitofusin LevelsPeriodontal DiseasesPeriodontitisGingivitisNCT06510608Erzincan University81
尚未招募
不适用
Saliva characteristics in health and diseaseCTRI/2018/01/011566Manipal College of Dental Sciences
进行中（未招募）
不适用
Explorative analysis of topical miltefosine application in adult patients with atopic dermatitis. - Miltefosin bei ADEUCTR2007-003471-39-DEProf. Dr. med. Margitta Worm
尚未招募
3 期
Comparison of the effect and toxicity between two options for the treatment of Mucosal Leishmaniasis: Miltefosin and Liposomal Anfotericin BRBR-5r93wnCentro de Pesquisa Rene Rachou, Fundação Oswaldo Cruz
尚未招募
1 期
A study to explain the importance of oral hygiene and maintenance of oral hygiene in gum disease patientsCTRI/2021/08/035360Vishnu JP